Dr. Deanne Tibbitts is a Research Assistant Professor in the Division of Oncological Sciences at Oregon Health and Science University, where she studies how sex- and gender-based factors influence cancer-related health outcomes during and after treatment. A native of Atlanta, Dr. Tibbitts obtained her bachelor's degree in Genetics and Cellular Biology from the University of Georgia and her PhD in Molecular and Medical Genetics at OHSU, where she studied molecular mechanisms of leukemia development and targeted cancer therapeutics. Dr. Tibbitts completed an NIH-funded clinical research fellowship in complementary and integrative health at the National University of Natural Medicine before returning to OHSU to pursue a postdoctoral fellowship in cancer survivorship. As a BIRCWH scholar, Dr. Tibbitts is conducting a prospective study of immune-related adverse events during cancer immunotherapy. This study will identify sex- and gender-based differences in symptom profiles and potential biological and clinical mechanisms to explain sex and gender differences in treatment-related symptoms. Dr. Tibbitts’s work also integrates passive measurement technology to explore the impact of cancer treatment on functioning during daily life. The goal of her work is to improve quality of life for women by better understanding their unique symptom biology in response to cancer treatment.